CIK 0001411685 · Non-accelerated filer<br>Smaller reporting company
Vistagen Therapeutics, Inc.
Sign in to watch- Ticker
- VTGN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Mar 31
- Incorporated
- NV
- Entity type
- operating
- EIN
- 205093315
- Phone
- 650-577-3600
- Business address
- 343 ALLERTON AVENUE, SOUTH SAN FRANCISCO, CA, 94080
- Former names
- Excaliber Enterprises, Ltd.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 51 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-08-29 | GIN JERRY B Director | Grant or award · Stock Option (Right to Buy) | +35,000 | 35,000 | ||
| 2018-08-29 | MCPARTLAND MARK A. VP CORPORATE DEVELOPMENT | Returned to the company · Stock Option (Right to Buy) | −125,000 | 0 | ||
| 2018-08-29 | MCPARTLAND MARK A. VP CORPORATE DEVELOPMENT | Grant or award · Stock Option (Right to Buy) | +125,000 | 125,000 | ||
| 2018-08-29 | MCPARTLAND MARK A. VP CORPORATE DEVELOPMENT | Returned to the company · Stock Option (Right to Buy) | −40,000 | 0 | ||
| 2018-08-29 | MCPARTLAND MARK A. VP CORPORATE DEVELOPMENT | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2018-08-29 | MCPARTLAND MARK A. VP CORPORATE DEVELOPMENT | Returned to the company · Stock Option (Right to Buy) | −100,000 | 0 | ||
| 2018-08-29 | MCPARTLAND MARK A. VP CORPORATE DEVELOPMENT | Grant or award · Stock Option (Right to Buy) | +100,000 | 250,000 | ||
| 2018-08-29 | Underdown Brian J. Director | Returned to the company · Stock Option (Right to Buy) | −500 | 0 | ||
| 2018-08-29 | Underdown Brian J. Director | Grant or award · Stock Option (Right to Buy) | +500 | 500 | ||
| 2018-08-29 | Underdown Brian J. Director | Returned to the company · Stock Option (Right to Buy) | −6,250 | 0 | ||
| 2018-08-29 | Underdown Brian J. Director | Grant or award · Stock Option (Right to Buy) | +6,250 | 6,250 | ||
| 2018-08-29 | Underdown Brian J. Director | Returned to the company · Stock Option (Right to Buy) | −2,500 | 0 | ||
| 2018-08-29 | Underdown Brian J. Director | Grant or award · Stock Option (Right to Buy) | +2,500 | 2,500 | ||
| 2018-08-29 | Underdown Brian J. Director | Returned to the company · Stock Option (Right to Buy) | −25,000 | 0 | ||
| 2018-08-29 | Underdown Brian J. Director | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2018-08-29 | Underdown Brian J. Director | Returned to the company · Stock Option (Right to Buy) | −25,000 | 0 | ||
| 2018-08-29 | Underdown Brian J. Director | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2018-08-29 | Underdown Brian J. Director | Returned to the company · Stock Option (Right to Buy) | −35,000 | 0 | ||
| 2018-08-29 | Underdown Brian J. Director | Grant or award · Stock Option (Right to Buy) | +35,000 | 35,000 | ||
| 2018-08-29 | Smith Mark Alan CHIEF MEDICAL OFFICER | Returned to the company · Stock Option (Right to Buy) | −180,000 | 0 |
Page 13 of 17 · 323 trades